Spectaire (SPEC) Competitors

Spectaire (NASDAQ:SPEC) and ThermoGenesis (NASDAQ:THMO) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Do institutionals and insiders believe in SPEC or THMO?

26.5% of Spectaire shares are owned by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are owned by institutional investors. 25.4% of Spectaire shares are owned by insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Is SPEC or THMO more profitable?

ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectaire	N/A	-81.22%	304.57%
ThermoGenesis	N/A	N/A	N/A

Which has preferable earnings & valuation, SPEC or THMO?

Spectaire has higher earnings, but lower revenue than ThermoGenesis.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectaire	N/A	N/A	$8.95M	N/A	N/A
ThermoGenesis	$9.61M	0.00	-$17.98M	-$5.14	N/A

Does the media refer more to SPEC or THMO?

In the previous week, Spectaire's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company	Overall Sentiment
Spectaire	Neutral
ThermoGenesis	Neutral

Which has more risk and volatility, SPEC or THMO?

Spectaire has a beta of -6.28, indicating that its share price is 728% less volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500.

Summary

ThermoGenesis beats Spectaire on 4 of the 7 factors compared between the two stocks.